Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
United States of America ex rel. John Doe v. Cephalon, Inc., et al
Case Number:
1:10-cv-06457
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 19, 2014
Whistleblower's Cephalon FCA Suit Headed To Pa. Court
A New York federal judge on Wednesday agreed to move a whistleblower suit alleging Cephalon Inc. promoted some of its drugs for off-label uses to boost sales to government-funded programs, finding that a similar suit in Pennsylvania was filed first.
-
September 13, 2013
Whistleblower Wants Cephalon FCA Suit Moved To Pa.
A whistleblower who once served as a senior-level manager at Cephalon Inc. urged a New York federal judge on Thursday to transfer his False Claims Act suit against the biopharmaceutical company to Pennsylvania federal court, where another similar case against the company is pending.
-
March 18, 2013
Cephalon Hit With FCA Suit Over Off-Label Marketing
Cephalon Inc. was hit with a whistleblower suit in New York federal court Friday claiming the drugmaker submitted hundreds of thousands of false claims to federal and state health care programs by promoting its leukemia and pain medications for unapproved off-label uses.